New Tool: ProSource
Check out our packaging and processing solutions finder, ProSource.

Rollprint: Anti-counterfeiting flexible packaging

Ghost is a proprietary new technology for composite flexible packaging materials to support medical device and pharmaceutical anti-counterfeiting efforts.

Ghost is a proprietary new technology for composite flexible packaging materials to support medical device and pharmaceutical anti-counterfeiting efforts.
Ghost is a proprietary new technology for composite flexible packaging materials to support medical device and pharmaceutical anti-counterfeiting efforts.

Rollprint Packaging Products, Inc.’s Ghost™ process creates an integrated, repeating watermark embedded in the composite flexible packaging material making it technically and economically challenging to duplicate. Companies have the flexibility to use corporate logos, brand names or other symbology for the easily visible, overt watermark, which provides visual confirmation to the user that the products being used are authentic.

Ghost is ideally suited for chevron pouches used in medical device applications (such as sutures, scalpels, prefilled syringes, artificial joints, catheters, etc.). The technology can also be used in conjunction with blister packs, packets, and packaging for other security-driven or luxury items.  These include electronic components, collectibles, documents, jewelry, etc.

Ghost gives companies a viable, cost-effective anticounterfeiting option. The proprietary technology can be used with a variety of material combinations including peelable and weld seal options used in conjunction with polyester, foil, nylon, and other substrates.

Companies currently using anti-counterfeiting measures typically employ covert options that add cost and frequently require specialized equipment. Examples include inks only visible under UV light and micro printing. Because the watermark is added concurrently during normal processing, Rollprint can usually add the feature at little or no additional cost.

Attempting to duplicate the watermark would require very specialized equipment with knowledge of proprietary, advanced technology, coupled with significant financial investment. This makes it a particularly challenging hurdle for counterfeiters to attempt.

“The World Health Organization reports that more than 8 percent of medical devices in circulation are counterfeit and more than 10 percent of global pharmaceutical commerce is counterfeit,” says Dwane Hahn, Vice President of Sales and Marketing, Rollprint. “These counterfeit devices and drugs not only pose a significant danger

Test Your Supply Chain Smarts
Take Healthcare Packaging's supply chain quiz to prove your knowledge!
Read More
Test Your Supply Chain Smarts
Discover Our Content Hub
Access Healthcare Packaging's free educational content library!
Read More
Discover Our Content Hub